SPIRIVA inhalation powder and SPIRIVA RESPIMAT are contraindicated in patients with a history of hypersensitivity to atropine or its derivatives, e.g. ipratropium or oxitropium or to any component of this product (see Precautions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
